Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 21, 2025, 20:57 UTC
  • 0

No Sony Walkman Refresh in Sight

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 21, 2025, 17:05 UTC
  • 1

AMD Leaks Upcoming Ryzen 5 9600X3D 3D V-Cache Gaming Chip

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 21, 2025, 16:48 UTC
  • 0

The White Lotus Season 4: Everything We Know So Far

Market reaction Comment Full text

9 Meters Biopharma, Inc. (NMTRQ)

  • Business News
  • June 21, 2025, 16:44 UTC
  • 0

Netflix’s Mindhunter Might Return — But As A Movie Trilogy, Not Season 3

Market reaction Comment Full text

Eli Lilly and Company (LLY)

  • Business News
  • June 21, 2025, 13:02 UTC
  • 0

Lillys oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medicine

Market reaction Comment Full text

Nutex Health Inc (NUTX)

  • Business News
  • June 21, 2025, 12:22 UTC
  • 0

GE HealthCare drives innovation in theranostics with latest technological advances

Market reaction Comment Full text

Perspective Therapeutics Inc (CATX)

  • Business News
  • June 21, 2025, 12:00 UTC
  • 0

Perspective Therapeutics Commences Recruitment for [212Pb]VMT-α-NET in the Third Dose Escalation Cohort of its Ongoing Phase 1/2a Clinical Trial

Market reaction Comment Full text

Perspective Therapeutics Inc (CATX)

  • Business News
  • June 21, 2025, 12:00 UTC
  • 0

Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2025 Annual Meeting

Market reaction Comment Full text

AstraZeneca (AZN)

  • Business News
  • June 21, 2025, 06:03 UTC
  • 0

Alexion data presented at EAN 2025 highlights its leadership and commitment to improving patient outcomes in rare neurological diseases

Market reaction Comment Full text

Organon & Co. (OGN)

  • Business News
  • June 21, 2025, 02:50 UTC
  • 2

ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - OGN

Market reaction Comment Full text
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Search

News categories

  • Technical Exchange News(9375)
  • Event(407)
  • SEC News(153224)
  • FDA Approval(8741)
  • Company Report(721)
  • Business News(104530)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin